OpenAlex
PricingAboutJobs
Log inGet started
Work

Does Ketamine Have Anti-Suicidal Properties? Current Status and Future Directions

HTML PDF

Year: 2015
Type: editorial
Source: CNS Drugs
DOI: 10.1007/s40263-015-0232-4
Authors: Rebecca B. Price, Sanjay J. Mathew
Institutions: University of Pittsburgh, Michael E. DeBakey VA Medical Center, Baylor College of Medicine
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: ketamine, suicidality, suicidal ideation, depression, bipolar depression, rapid antidepressant effects, suicide prevention, mechanism of action, major depressive disorder
SDG: Good health and well-being

Open Access status: bronze

Funders: AstraZeneca, Sanofi, Cerecor, National Institutes of Health, Genentech, National Institute of Mental Health, Janssen Research and Development
Awards: Optimization of IV Ketamine for Treatment Resistant Major Depression, Neural Dimensions of Attention Bias Modification for Transdiagnostic Anxiety
OpenAlex ID: W2057360675
Cites: 47
Cited by: 52
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security